Professional Training in Psychedelic-Assisted Therapy

The Psychedelic-Assisted Therapy Landscape in 2026

Psychedelic-assisted therapy (PAT) refers to therapeutic protocols in which psychedelic substances are administered as part of a structured therapeutic process — involving careful patient selection, preparation sessions, one or more medicine sessions with trained professionals present, and structured integration therapy afterward. This is categorically different from recreational use or informal spiritual practice, though it shares pharmacological underpinnings with both.

As of 2026, the professional landscape is defined by convergence: MDMA-assisted therapy for PTSD and psilocybin for treatment-resistant depression are at or near regulatory decision points; Oregon and Colorado have launched operational legal therapeutic frameworks; Australia has a TGA-approved prescribing pathway; and training programs have proliferated from a handful a decade ago to dozens today. The demand for trained, ethical practitioners substantially exceeds supply — and the quality and rigor of available training programs varies enormously.

This creates both opportunity and risk for professionals entering the field. The opportunity is genuine: participating in the development of what may become a significant component of mental health care. The risk is that inadequate training, insufficient ethical grounding, and working outside legal authorization can cause serious harm to vulnerable people and damage the field's credibility.

MAPS Training Programs

The Multidisciplinary Association for Psychedelic Studies (MAPS) pioneered formalized PAT training through their MDMA-assisted therapy research program, developed across three decades of clinical work culminating in Phase 3 FDA trials.

MAPS Therapy Training Program

MAPS' primary training is designed for licensed mental health professionals to serve as therapists in MDMA-assisted therapy research and, eventually, post-approval clinical practice. The program is structured in stages:

• Stage 1 — Didactic Training: Online modules covering MDMA pharmacology, the MAPS therapeutic model, ethics, session facilitation principles, working with trauma, and the inner healing intelligence framework. Available to licensed clinicians who meet prerequisites.
• Stage 2 — Observation: Observing trained therapist dyads conducting MDMA-AT sessions (with participant consent). Develops familiarity with the clinical environment before direct participation.
• Stage 3 — Therapist in Training: Serving as co-therapist in supervised sessions under the direction of experienced lead therapists. Integration of didactic learning with direct clinical experience.
• Stage 4 — Supervision and Consultation: Ongoing case consultation and supervision as competency develops.

The MAPS model uses dyadic therapy (two therapists per participant) rather than individual therapy. This design choice reflects both safety considerations (the vulnerability of altered states) and the specific demands of the long MDMA-AT session (6–8 hours).

The inner healing intelligence model that MAPS training centers does not require personal MDMA experience — MAPS uses non-drug introspective processes in training to develop therapists' capacity to work with internal states. This distinguishes MAPS from programs that mandate personal psychedelic experience.

Zendo Project Training

The Zendo Project (maps.org/zendo) is MAPS' harm reduction program, and their training is distinct from clinical PAT training. Zendo trains volunteers and peer support workers in psychedelic crisis support in non-clinical settings (festivals, community contexts). The Zendo model centers four principles: safe space, sitting not guiding, talk through not down, and difficult is not the same as bad. This is harm-reduction facilitation, not therapy. It requires no clinical license. Zendo training is widely recommended for anyone working in festival or event harm reduction contexts.

California Institute of Integral Studies (CIIS)

CIIS (ciis.edu) in San Francisco offers what is widely considered the most academically rigorous psychedelic-specific professional certificate available in the US outside of degree programs.

Certificate in Psychedelic-Assisted Therapies and Research

This professional certificate is designed for licensed clinicians — therapists, psychiatrists, psychologists, and social workers — who want comprehensive preparation for PAT practice. Key features:

• Prerequisites: Active mental health licensure required. Unlicensed practitioners and students cannot enroll.
• Duration: Approximately 9 months, structured as a cohort
• Format: Combination of online learning and intensive in-person residential modules (typically 2–3 residencies)
• Curriculum breadth: Neuropharmacology of psychedelics, classical and transpersonal therapeutic frameworks, clinical models (MAPS, EMBARK, ACE), ethics specific to PAT, cultural competency and indigenous perspectives, safety protocols, adverse event management, supervised practicum elements, integration frameworks, and research literacy
• Faculty: Includes researchers, clinicians, and scholars with active involvement in the field — not only instructors but practitioners
• CEU credit: Continuing education units recognized by most state licensing boards for licensed professionals
• Cost: Typically $5,000–$15,000 as of 2026. Financial aid may be available; verify current cost directly with CIIS.

CIIS's program is frequently cited by practitioners as the most thorough preparation available. Its depth distinguishes it from shorter programs — the 9-month cohort format allows genuine integration of learning across the full scope of PAT competencies.

Naropa University Programs

Naropa University (naropa.edu) in Boulder, Colorado is a contemplative liberal arts university with roots in the Buddhist tradition and a long history of integrating contemplative practice with academic inquiry. Their psychedelic programs are distinctive in their emphasis on the spiritual and somatic dimensions alongside clinical competency.

Graduate Certificate in Psychedelic-Assisted Therapy

• Graduate-level certificate, available to licensed clinicians and in some tracks to graduate students in clinical programs
• Integrates somatic (body-centered) therapeutic approaches — particularly the Hakomi method — with PAT curriculum
• Strong emphasis on personal inner work, contemplative practice, and the practitioner's own psychological development as foundational to clinical competency
• Affiliation with Buddhist-informed transpersonal psychology distinguishes Naropa from more conventional clinical programs
• Integration with the MA in Transpersonal Counseling Psychology for students who want a full degree pathway

Naropa is well suited to practitioners who want to engage the existential, spiritual, and somatic dimensions of psychedelic therapy with the same rigor as pharmacology and clinical skills. Its contemplative orientation is both its distinctive strength and potentially a poor fit for practitioners who want a primarily biomedical clinical frame.

The EMBARK Model and NYU Training

EMBARK (Existential, Meaning-centered, Body-centered, Altered states of consciousness, Relational, Kriya/spiritual) is an integrative therapeutic framework for psilocybin-assisted therapy developed by researchers at NYU Grossman School of Medicine and Columbia University. Developed principally by Dr. Anthony Bossis, Dr. Jeffrey Guss, and colleagues, it was designed specifically to address the full scope of what psilocybin sessions involve — including existential and spiritual content that standard CBT or psychodynamic frameworks do not adequately address.

EMBARK is deliberately integrative: it synthesizes existential therapy, meaning-centered therapy (Victor Frankl tradition), somatic and body-centered approaches, relational therapy, and attention to altered states as a specific clinical domain. The Kriya/spiritual element acknowledges that many psilocybin experiences have spiritual character and that practitioners must be able to work with this dimension professionally and respectfully.

EMBARK training is available through workshops and supervision programs affiliated with NYU. It is not a standalone training institute but rather a therapeutic model taught within academic and professional development contexts. Check med.nyu.edu/psychedelic-medicine for current training offerings.

What Comprehensive PAT Training Includes

Reputable, comprehensive PAT training programs cover a core curriculum spanning these domains:

Pharmacology and Medicine

• Mechanisms of action of psilocybin, MDMA, ketamine, and related compounds at receptor level
• Dose-response relationships and variability
• Drug interactions — particularly MAOI interactions, lithium, SSRIs, stimulants
• Medical contraindications and cardiovascular considerations
• Managing adverse events including serotonin syndrome, cardiac events, and psychological crises
• Pharmacokinetics, onset, peak, and duration profiles relevant to session management

Session Facilitation

• Session structure and flow (preparation, dosing, integration arc)
• The role of music, setting, and physical environment in PAT
• Working with non-ordinary states — how to be present without directing or interpreting
• Physical presence and appropriate touch (a significant and nuanced topic — see ethics section)
• Managing the range from mild to intensely challenging experiences in session
• Dyadic co-therapist coordination and communication
• Post-session transition and handoff

Preparation and Integration

• Conducting preparation sessions — building therapeutic alliance, intention work, psychoeducation, expectation calibration
• Informed consent process for PAT specifically (more complex than standard therapy consent given the experiential unknowns)
• Integration frameworks — how to help clients make meaning from and implement insights from sessions
• Supporting integration over time — the medium and long term, not just the immediate post-session period
• When to refer for additional support (trauma specialist, psychiatrist, spiritual director)

Ethics Specific to PAT

Standard mental health ethics training does not adequately prepare practitioners for the specific ethical challenges of PAT. Dedicated ethics curricula in PAT programs address:

• Power dynamics in altered states: Psychedelic states produce heightened suggestibility and vulnerability. The therapeutic relationship during a session is asymmetric in ways that exceed ordinary therapy — the participant cannot effectively advocate for themselves if boundaries are crossed while under the influence.
• Transference and countertransference: The intense relational qualities of PAT sessions amplify transference dynamics. Therapists must maintain strong professional boundaries while being genuinely warm and present — a combination that requires specific training.
• Touch policies: Physical touch (hand-holding, grounding contact) is common in PAT facilitation but must operate within clearly established, consent-based policies. The field has specific ethical guidelines on appropriate touch, developed partly in response to documented cases of inappropriate touch leading to sexual misconduct. Explicit pre-session discussion of touch policies and ongoing consent practices are standard in reputable training.
• Appropriate self-disclosure: Whether and how practitioners disclose their own psychedelic experiences. Training programs take different positions; the standard requires that self-disclosure serve the client's interests, not the practitioner's needs.
• Dual relationships: The intense quality of PAT relationships creates heightened risk of boundary erosion into friendship, spiritual teacher-student dynamics, or romantic connection. Clear professional role boundaries must be explicitly maintained.
• Cultural humility and indigenous roots: Many psychedelic traditions have indigenous roots that deserve respect and attribution. Practitioners should understand this history and approach it with genuine humility, not cultural appropriation for marketing purposes.
• Financial equity: The high cost of PAT sessions creates access barriers that raise equity concerns. Ethical practitioners consider sliding scale options, advocacy for insurance coverage, and community access programs.

Legal Requirements for Practice

Legal requirements for PAT practice vary significantly by jurisdiction and by role. Understanding this landscape before pursuing training is essential.

United States — Federal Level

Psilocybin remains Schedule I under the federal Controlled Substances Act. This means that administering psilocybin in a therapeutic context outside of an FDA-authorized Investigational New Drug (IND) application (i.e., outside of approved clinical trials) is federally illegal — regardless of state law. Oregon and Colorado state laws do not override federal scheduling. Clinical trial participation is the only federally legal pathway to administer psilocybin.

Oregon Psilocybin Services — Facilitator Licensing

Oregon's Psilocybin Services Act (Measure 109) created the first state regulatory framework for psilocybin therapeutic services. Key elements of the facilitator pathway:

• New occupational category: "Psilocybin Facilitator" — a state license specific to Oregon that does not require prior mental health licensure
• Training requirement: Completion of a state-approved facilitator training program. Oregon Health Authority (OHA) approves and lists training programs. The minimum hours requirement is currently 160 hours, including practicum experience.
• Background check: Required as part of licensing. Certain criminal history may disqualify applicants — review OHA's disqualifying criteria before investing in training.
• Application and fees: License application submitted to OHA with required documentation and fees. Approval process takes several weeks.
• Scope of practice: Oregon facilitators may not provide therapy, diagnose conditions, or practice medicine. Their role is limited to presence and support during psilocybin sessions at licensed service centers.
• Service center requirement: Facilitators must work at or be affiliated with a separately licensed service center. Independent practice is not permitted.
• License renewal: Licenses require renewal with continuing education. Check current OHA requirements for CE hours and renewal timelines.
• Oregon residency: Not required. Out-of-state practitioners may hold Oregon facilitator licenses.

The OHA Psilocybin Services website (oregon.gov/oha/psilocybin) is the authoritative source for current requirements. Requirements are subject to change as the program matures.

Colorado Natural Medicine Program

Colorado's Natural Medicine Health Act (Proposition 122) is implementing a similar licensed healing center framework. Colorado's program includes psilocybin mushrooms, mescaline-containing cacti, and DMT, with ibogaine added in 2026. The Colorado Natural Medicine Division (CDPHE) oversees licensing for both facilitators and healing centers. Requirements are being finalized and implemented through 2024–2026 — check cdphe.colorado.gov for current facilitator licensing requirements.

For Licensed Mental Health Professionals

Licensed therapists, social workers, psychologists, and psychiatrists who want to integrate PAT into their practice face a specific legal landscape:

• What is currently legal everywhere: Psychedelic integration therapy — working with clients to process and integrate their own psychedelic experiences, without administering any substance. This is standard therapy and legal as a mental health service in all US states.
• What is legal in Oregon and Colorado: Serving as a licensed facilitator (or employing licensed facilitators) at a licensed service center, providing the non-therapeutic presence and support role. Therapists can additionally provide separate integration therapy services.
• What is legal nationwide in trials: Serving as a therapist in FDA-authorized IND clinical trials, with appropriate credentials and IRB approval.
• What is not currently legal outside OR/CO: Administering or providing psilocybin as part of therapy outside trial settings, regardless of clinical license.
• Consult a healthcare attorney familiar with psychedelic practice before establishing any clinical practice involving psychedelic substances.

The Certification Debate

The PAT field has ongoing, sometimes contentious debates about what professional certification should look like. Understanding the key arguments positions you to evaluate programs and policy developments intelligently.

Key Questions in the Field

• Prior mental health licensure vs. new practitioner category: Should PAT practitioners require mental health licensure (the clinical model), or should a new practitioner category (the Oregon facilitator model) be the primary pathway? Arguments for licensure: complex psychopathology requires clinical training; liability needs clinical framing; the therapeutic relationship is clinical. Arguments for new category: licensure gatekeeps access to a broader range of potential effective practitioners; indigenous and traditional practitioners aren't MHPs but have relevant expertise; not all PAT is therapy.
• Personal experience requirements: Should practitioners be required to have personal psychedelic experience? Arguments for: understanding altered states from the inside improves facilitation capacity; personal integration work is part of ethical preparation. Arguments against: personal experience is not a valid proxy for clinical competency; makes formal research participation difficult; creates illegal requirement outside trial settings; may unduly favor those with prior access.
• Standardization vs. diversity of approaches: A standardized curriculum protects quality but may inappropriately favor specific cultural or therapeutic traditions. Indigenous and ceremonial contexts have operated effectively without Western certification standards for centuries. The risk of over-standardization is that it excludes practitioners with legitimate alternative traditions of preparation.
• Who certifies the certifiers: As training programs proliferate, who evaluates their quality? Professional organizations (Psychedelic Medicine Association, Association of Psychedelic Practitioners) are working to develop field-wide standards, but none yet carry regulatory weight. The current absence of independent certification accreditation means program quality verification falls entirely on prospective students.

Vetting and Selecting a Training Program

Given program proliferation and quality variation, applying rigorous vetting criteria before committing time and money is essential.

Questions to Ask Any Program

• Is the institution regionally accredited (for academic programs)? Do they offer CE credits recognized by your licensing board?
• Who teaches the program? Are faculty active clinicians or researchers with published work, or primarily administrators and guest lecturers?
• What is the curriculum? Does it cover pharmacology, ethics, legal context, contraindications, adverse event management, AND clinical facilitation skills — or does it emphasize only one area?
• Does it include practicum hours (supervised actual session experience), or only didactic content?
• What is the cost, and what does it include? Are there hidden fees for materials, retreats, or supervision hours?
• Can they provide alumni contacts you can speak with about their experience?
• What does completion qualify you to do, legally, in your jurisdiction? Be specific.
• Does the program have any quality oversight beyond self-reporting? Are they affiliated with professional associations that have codes of ethics?
• What is their policy on personal psychedelic experience in training? If included, is it within legal jurisdictions?
• What are refund and grievance policies?

Red Flags in Training Programs

• Programs that promise certification will allow you to "practice psychedelic therapy" without clarifying the actual legal pathway
• Very high cost ($20,000+) without commensurate accreditation, faculty credentials, or demonstrated placement outcomes
• No mention of ethics, legal requirements, or contraindications in curriculum description
• Faculty with no verifiable research or clinical publications in psychedelic medicine
• Claims that their certificate is equivalent to a clinical license for PAT
• Programs that facilitate illegal psychedelic administration outside appropriate legal contexts

Continuing Education and Staying Current

The PAT field is evolving faster than any fixed training curriculum can track. Staying current requires ongoing engagement beyond initial certification.

Professional Organizations

• Association of Psychedelic Practitioners (APP): Emerging professional membership organization working to develop ethical standards and community of practice
• Psychedelic Medicine Association (PMA): Professional membership focused on clinical integration; conferences and CE programming
• Chacruna Institute (chacruna.net): Free educational resources on policy, ethics, cultural context, and clinical developments
• MIND Foundation (mind-foundation.org): European-based professional and research network; conferences and publications

Journals and Publications

• Journal of Psychedelic Studies: Peer-reviewed; primary academic journal for the field
• Psychopharmacology: Major pharmacology journal frequently publishing psilocybin and psychedelic research
• Psychedelic Alpha newsletter: Best source for regulatory and industry developments
• MAPS newsletter and blog: Research and training developments from MAPS' perspective
• Following researchers Robin Carhart-Harris, Matthew Johnson, Albert Garcia-Romeu, Anthony Bossis, Michael Pollan, Jeffrey Guss, and others on academic and public platforms provides early access to new findings and commentary

Supervision and Peer Consultation

Ongoing supervision from experienced PAT practitioners is one of the most important continuing education practices available. The intensity of PAT sessions, the ethical challenges, and the novelty of the work all make peer consultation and supervision particularly valuable — more so than in conventional therapy practices. Building a consultation group with other PAT practitioners provides a container for processing difficult sessions, ethical dilemmas, and professional development questions that formal CE programs cannot address.

Frequently Asked Questions

See also: for the broader landscape of career tracks (therapist, integration coach, researcher, harm reduction) see Professional Training; for certification-body comparisons (MAPS, Synthesis Institute, academic pathways) see Psychedelic Therapy Certifications.